Jackson Financial Inc.'s income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Jackson Financial Inc. reported revenue of $6.7B (+104.3% year on year) and net income of $72.0M (-92.6% year on year).
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Fee income | $8.0B | $8.1B | $7.7B | — |
| Premiums | $149.0M | $146.0M | $147.0M | $132.0M |
| Net investment income excluding funds withheld assets | $2.3B | $1.8B | $1.8B | — |
| Net investment income on funds withheld assets | $855.0M | $1.0B | $1.2B | — |
| Total net investment income | $3.2B | $2.9B | $2.9B | $2.8B |
| Net gains (losses) on derivatives and investments | ($3.4B) | ($6.8B) | ($5.9B) | $3.9B |
| Net gains (losses) on funds withheld reinsurance treaties | ($1.3B) | ($1.1B) | ($1.8B) | — |
| Total net gains (losses) on derivatives and investments | ($4.7B) | ($7.9B) | ($7.7B) | — |
| Other income | $61.0M | $44.0M | $67.0M | $85.0M |
| Total revenues | $6.7B | $3.3B | $3.2B | $14.6B |
| Death, other policy benefits and change in policy reserves, net of deferrals | $927.0M | $868.0M | $965.0M | $2.3B |
| (Gain) loss from updating future policy benefits cash flow assumptions, net | $44.0M | $46.0M | $102.0M | — |
| Market risk benefits (gains) losses, net | $605.0M | ($3.8B) | ($3.9B) | — |
| Interest credited on other contract holder funds, net of deferrals and amortization | $1.2B | $1.1B | $1.1B | $862.0M |
| Interest expense | $100.0M | $101.0M | $185.0M | $113.0M |
| Operating costs and other expenses, net of deferrals | $2.8B | $2.8B | $2.5B | $2.4B |
| Amortization of deferred acquisition costs | $1.1B | $1.1B | $1.2B | $1.7B |
| Total benefits and expenses | $6.8B | $2.2B | $2.2B | $7.4B |
| Pretax income (loss) | ($114.0M) | $1.0B | $958.0M | $7.1B |
| Income tax expense (benefit) | ($186.0M) | $46.0M | $4.0M | $1.4B |
| Net income (loss) | $72.0M | $976.0M | $954.0M | $5.7B |
| Less: Net income (loss) attributable to noncontrolling interests | $45.0M | $30.0M | $20.0M | $43.0M |
| Net income (loss) attributable to Jackson Financial Inc. | $27.0M | $946.0M | $934.0M | $5.7B |
| Less: Dividends on preferred stock | $44.0M | $44.0M | $35.0M | — |
| Net income (loss) attributable to Jackson Financial Inc. common shareholders, Basic | ($17.0M) | $902.0M | $899.0M | — |
| Net income (loss) attributable to Jackson Financial Inc. common shareholders, Diluted | ($17.0M) | $902.0M | $899.0M | — |
| Basic (in usd per share) | -$0.24 | $11.86 | $10.99 | $66.62 |
| Diluted (in usd per share) | -$0.24 | $11.74 | $10.76 | $64.23 |
| Line item | Jun 30, 2026 · Q2 | Mar 31, 2026 · Q1 | Sep 30, 2025 · Q3 | Jun 30, 2025 · Q2 |
|---|---|---|---|---|
| Fee income | $2.0B | $2.0B | $2.0B | $1.9B |
| Premiums | $38.0M | $28.0M | $31.0M | $40.0M |
| Net investment income excluding funds withheld assets | $727.0M | $541.0M | $653.0M | $491.0M |
| Net investment income on funds withheld assets | $201.0M | $199.0M | $203.0M | $227.0M |
| Total net investment income | $928.0M | $740.0M | $856.0M | $718.0M |
| Net gains (losses) on derivatives and investments | ($2.5B) | $283.0M | ($1.1B) | ($2.9B) |
| Net gains (losses) on funds withheld reinsurance treaties | ($297.0M) | ($159.0M) | ($379.0M) | ($327.0M) |
| Total net gains (losses) on derivatives and investments | ($2.8B) | $124.0M | ($1.5B) | ($3.2B) |
| Other income | $18.0M | $12.0M | $15.0M | $16.0M |
| Total revenues | $168.0M | $2.9B | $1.4B | ($471.0M) |
| Death, other policy benefits and change in policy reserves, net of deferrals | $221.0M | $258.0M | $230.0M | $256.0M |
| (Gain) loss from updating future policy benefits cash flow assumptions, net | $20.0M | $18.0M | $13.0M | $12.0M |
| Market risk benefits (gains) losses, net | ($2.1B) | $1.7B | ($226.0M) | ($2.2B) |
| Interest credited on other contract holder funds, net of deferrals and amortization | $320.0M | $315.0M | $313.0M | $295.0M |
| Interest expense | $27.0M | $25.0M | $25.0M | $25.0M |
| Operating costs and other expenses, net of deferrals | $687.0M | $735.0M | $714.0M | $681.0M |
| Amortization of deferred acquisition costs | $281.0M | $281.0M | $275.0M | $274.0M |
| Total benefits and expenses | ($497.0M) | $3.3B | $1.3B | ($660.0M) |
| Total benefits and expenses | $665.0M | ($400.0M) | $72.0M | $189.0M |
| Income tax expense | $5.0M | $20.0M | ($19.0M) | $4.0M |
| Net income (loss) | $660.0M | ($420.0M) | $91.0M | $185.0M |
| Less: Net income (loss) attributable to noncontrolling interests | $5.0M | $4.0M | $15.0M | $6.0M |
| Net income (loss) attributable to Jackson Financial Inc. | $655.0M | ($424.0M) | $76.0M | $179.0M |
| Less: Dividends on preferred stock | $11.0M | $11.0M | $11.0M | $11.0M |
| Net income (loss) attributable to Jackson Financial Inc. common shareholders, Basic | $644.0M | ($435.0M) | $65.0M | $168.0M |
| Net income (loss) attributable to Jackson Financial Inc. common shareholders, Diluted | $644.0M | ($435.0M) | $65.0M | $168.0M |
| Basic (in usd per share) | $9.18 | -$6.24 | $0.93 | $2.34 |
| Diluted (in usd per share) | $9.16 | -$6.24 | $0.92 | $2.34 |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Debt Securities, available-for-sale, net of allowance for credit losses of $11 and $39 at December 31, 2025 and 2024, respectively (amortized cost: 2025 $50,491; 2024 $45,007) | $47.3B | $40.3B | $40.4B | $42.5B |
| Debt Securities, at fair value under fair value option | $3.5B | $3.0B | $2.2B | $2.2B |
| Equity securities, at fair value | $172.0M | $197.0M | $394.0M | $393.0M |
| Mortgage loans, net of allowance for credit losses of $133 and $121 at December 31, 2025 and 2024, respectively | $9.9B | $9.5B | — | — |
| Mortgage loans, at fair value under fair value option | $324.0M | $449.0M | $481.0M | $582.0M |
| Policy loans (including $3,537 and $3,489 at fair value under the fair value option at December 31, 2025 and 2024, respectively) | $4.4B | $4.4B | $4.4B | $4.4B |
| Freestanding derivative instruments | $448.0M | $297.0M | $390.0M | $1.3B |
| Other invested assets | $3.2B | $2.9B | $2.5B | $3.6B |
| Total investments | $69.2B | $61.0B | $60.9B | $65.9B |
| Cash and cash equivalents | $5.7B | $3.8B | $2.7B | $4.3B |
| Accrued investment income | $634.0M | $529.0M | $512.0M | $514.0M |
| Deferred acquisition costs | $11.7B | $11.9B | $12.3B | $13.4B |
| Reinsurance recoverable, net of allowance for credit losses of $30 and $27 at December 31, 2025 and 2024, respectively | $19.5B | $21.8B | $25.4B | $29.6B |
| Reinsurance recoverable on market risk benefits, at fair value | $118.0M | $121.0M | $149.0M | — |
| Market risk benefit assets, at fair value | $7.9B | $8.9B | $6.7B | — |
| Deferred income taxes, net | $719.0M | $480.0M | $640.0M | $385.0M |
| Other assets | $637.0M | $787.0M | $1.3B | $946.0M |
| Separate account assets | $236.5B | $229.1B | $219.7B | $195.9B |
| Total assets | $352.6B | $338.4B | $330.3B | $311.1B |
| Reserves for future policy benefits and claims payable | $10.9B | $11.1B | $11.9B | $14.3B |
| Other contract holder funds | $67.7B | $58.3B | $55.3B | $58.2B |
| Market risk benefit liabilities, at fair value | $3.8B | $3.8B | $4.8B | — |
| Funds withheld payable under reinsurance treaties (including $3,723 and $3,667 at fair value under the fair value option at December 31, 2025 and 2024, respectively) | $15.0B | $16.7B | $20.0B | $23.0B |
| Long-term debt | $2.0B | $2.0B | $2.0B | $2.6B |
| Repurchase agreements and securities lending payable | $1.0B | $1.6B | $19.0M | $1.0B |
| Collateral payable for derivative instruments | $58.0M | $150.0M | $780.0M | $689.0M |
| Freestanding derivative instruments | $14.3B | $361.0M | $1.2B | $2.1B |
| Other liabilities | $5.1B | $5.3B | $4.3B | $2.4B |
| Separate account liabilities | $236.5B | $229.1B | $219.7B | $195.9B |
| Total liabilities | $342.2B | $328.5B | $319.9B | $301.9B |
| Series A non-cumulative preferred stock and additional paid in capital, $1.00 par value per share: 24,000 shares authorized; 22,000 shares issued and outstanding at December 31, 2025 and December 31, 2024; liquidation preference $25,000 per share (see Note 23) | $533000000.00 | $533000000.00 | $533000000.00 | — |
| Common stock; 1,000,000,000 shares authorized, $0.01 par value per share and 66,825,632 and 73,380,643 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively (see Note 23) | $1000000.00 | $1000000.00 | $1000000.00 | $1000000.00 |
| Additional paid-in capital | $6.1B | $6.0B | $6.0B | $6.1B |
| Treasury stock, at cost; 27,662,683 and 21,107,672 shares at December 31, 2025 and 2024, respectively | -1.6B | -1.0B | -599.0M | -443.0M |
| Accumulated other comprehensive income (loss), net of tax expense (benefit) of $(377) in 2025 and $(311) in 2024 | ($2.5B) | ($3.5B) | ($2.8B) | ($5.5B) |
| Retained earnings | $7.5B | $7.7B | $7.0B | $8.3B |
| Total shareholders' equity | $10.0B | $9.8B | $10.2B | $8.4B |
| Noncontrolling interests | $389.0M | $218.0M | $164.0M | $732.0M |
| Total equity | $10.3B | $10.0B | $10.3B | $9.2B |
| Total liabilities and equity | $352.6B | $338.4B | $330.3B | $311.1B |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 |
|---|---|---|---|---|
| Debt Securities, available-for-sale, net of allowance for credit losses of $24 and $11 at June 30, 2026 and December 31, 2025, respectively (amortized cost: 2026 $55,815; 2025 $50,491) | $52.2B | $48.6B | $46.1B | $43.8B |
| Debt Securities, at fair value under fair value option | $3.5B | $3.4B | $3.5B | $3.3B |
| Equity securities, at fair value | $262.0M | $243.0M | $180.0M | $177.0M |
| Mortgage loans, net of allowance for credit losses of $176 and $133 at June 30, 2026 and December 31, 2025, respectively | $10.4B | $10.2B | $9.6B | $9.5B |
| Mortgage loans, at fair value under fair value option | $595.0M | $196.0M | $349.0M | $393.0M |
| Policy loans (including $3,617 and $3,537 at fair value under the fair value option at June 30, 2026 and December 31, 2025, respectively) | $4.5B | $4.4B | $4.5B | $4.5B |
| Freestanding derivative instruments | $422.0M | $701.0M | $486.0M | $384.0M |
| Other invested assets | $3.4B | $3.2B | $3.0B | $2.9B |
| Total investments | $75.3B | $71.0B | $67.7B | $65.0B |
| Cash and cash equivalents | $6.0B | $5.5B | $4.6B | $3.8B |
| Accrued investment income | $714.0M | $636.0M | $585.0M | $561.0M |
| Deferred acquisition costs | $11.7B | $11.6B | $11.7B | $11.7B |
| Reinsurance recoverable, net of allowance for credit losses of $31 and $30 at June 30, 2026 and December 31, 2025, respectively | $18.3B | $18.9B | $20.1B | $20.4B |
| Reinsurance recoverable on market risk benefits, at fair value | $109.0M | $121.0M | $116.0M | $111.0M |
| Market risk benefit assets, at fair value | $8.0B | $6.7B | $8.5B | $8.7B |
| Deferred income taxes, net | $609.0M | $610.0M | $573.0M | $449.0M |
| Other assets | $917.0M | $905.0M | $757.0M | $823.0M |
| Separate account assets | $245.4B | $223.5B | $239.0B | $232.2B |
| Total assets | $367.1B | $339.5B | $353.6B | $343.7B |
| Reserves for future policy benefits and claims payable | $10.6B | $10.7B | $10.9B | $10.9B |
| Account values with crediting rates | $73.3B | — | — | — |
| Market risk benefit liabilities, at fair value | $3.4B | $4.0B | $3.7B | $3.6B |
| Funds withheld payable under reinsurance treaties (including $3,806 and $3,723 at fair value under the fair value option at June 30, 2026 and December 31, 2025, respectively) | $14.1B | $14.5B | $15.5B | $15.7B |
| Debt | $2.8B | $2.0B | $2.0B | $2.0B |
| Repurchase agreements and securities lending payable | $477.0M | $505.0M | $1.0B | $1.2B |
| Collateral payable for derivative instruments | $14.0M | $343.0M | $92.0M | $125.0M |
| Freestanding derivative instruments | $19.8B | $13.1B | $12.9B | $348.0M |
| Other Liabilities | $5.9B | $5.2B | $5.2B | $5.0B |
| Separate account liabilities | $245.4B | $223.5B | $239.0B | $232.2B |
| Total liabilities | $356.6B | $329.6B | $343.1B | $333.1B |
| Series A non-cumulative preferred stock and additional paid in capital, $1.00 par value per share: 24,000 shares authorized; 22,000 shares issued and outstanding at June 30, 2026 and December 31, 2025; liquidation preference $25,000 per share (see Note 19) | $533000000.00 | $533000000.00 | $533000000.00 | $533000000.00 |
| Common stock; 1,000,000,000 shares authorized, $0.01 par value per share and 68,185,286 and 66,825,632 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively (see Note 19) | $1000000.00 | $1000000.00 | $1000000.00 | $1000000.00 |
| Additional paid-in capital | $6.4B | $6.4B | $6.1B | $6.0B |
| Treasury stock, at cost; 26,303,029 and 27,662,683 shares at June 30, 2026 and December 31, 2025, respectively | -1.9B | -1.7B | -1.5B | -1.3B |
| Accumulated other comprehensive income (loss), net of tax expense (benefit) of $(286) and $(377) at June 30, 2026 and December 31, 2025, respectively | ($2.6B) | ($2.7B) | ($2.6B) | ($2.6B) |
| Retained earnings | $7.5B | $7.0B | $7.7B | $7.7B |
| Total shareholders' equity | $10.0B | $9.5B | $10.2B | $10.4B |
| Noncontrolling interests | $512.0M | $404.0M | $272.0M | $248.0M |
| Total equity | $10.5B | $9.9B | $10.5B | $10.6B |
| Total liabilities and equity | $367.1B | $339.5B | $353.6B | $343.7B |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Net income (loss) | $72.0M | $976.0M | $954.0M | $5.7B |
| Net realized losses (gains) on investments | $116.0M | $11.0M | $554.0M | $359.0M |
| Net losses (gains) on derivatives | $3.2B | $6.8B | $5.3B | ($2.0B) |
| Net losses (gains) on funds withheld reinsurance treaties | $1.3B | $1.1B | $1.8B | ($2.2B) |
| Net (gain) loss on market risk benefits | $605.0M | ($3.8B) | ($3.9B) | — |
| (Gain) loss from updating future policy benefits cash flow assumptions, net | $44.0M | $46.0M | $102.0M | — |
| Interest credited on other contract holder funds, gross | $1.2B | $1.1B | $1.1B | $862.0M |
| Mortality, expense and surrender charges | ($521.0M) | ($545.0M) | ($528.0M) | ($530.0M) |
| Amortization of discount and premium on investments | ($39.0M) | ($33.0M) | ($27.0M) | $11.0M |
| Deferred income tax expense (benefit) | ($173.0M) | $294.0M | ($207.0M) | $1.4B |
| Share-based compensation | $132.0M | $191.0M | $107.0M | $131.0M |
| Accrued investment income | ($105.0M) | ($17.0M) | $2.0M | ($11.0M) |
| Deferred acquisition costs | $227.0M | $415.0M | $622.0M | $1.1B |
| Funds withheld, net of reinsurance | $116.0M | $211.0M | ($20.0M) | ($402.0M) |
| Future policy benefits | ($421.0M) | ($777.0M) | ($731.0M) | — |
| Other assets and liabilities, net | ($61.0M) | ($133.0M) | $123.0M | $724.0M |
| Net cash provided by (used in) operating activities | $5.8B | $5.8B | $5.3B | $5.2B |
| Debt securities | $8.4B | $10.5B | $11.5B | $11.5B |
| Equity securities | $46.0M | $289.0M | $316.0M | $84.0M |
| Mortgage loans | $1.6B | $1.8B | $2.5B | $1.7B |
| Debt securities | ($14.5B) | ($11.7B) | ($8.2B) | ($11.6B) |
| Equity securities | ($21.0M) | ($16.0M) | ($200.0M) | ($249.0M) |
| Mortgage loans | ($1.9B) | ($1.1B) | ($1.6B) | ($1.8B) |
| Settlements related to derivatives and collateral on investments | ($1.1B) | ($6.5B) | ($5.5B) | ($674.0M) |
| Other investing activities | ($238.0M) | ($339.0M) | $623.0M | ($343.0M) |
| Net cash provided by (used in) investing activities | ($7.8B) | ($7.1B) | ($592.0M) | ($1.4B) |
| Deposits | $27.4B | $20.1B | $14.2B | $18.5B |
| Withdrawals | ($42.2B) | ($39.4B) | ($29.1B) | ($25.2B) |
| Net transfers from (to) separate accounts | $20.8B | — | — | — |
| Proceeds from (payments on) repurchase agreements and securities lending | ($516.0M) | $1.5B | ($1.0B) | ($541.0M) |
| Net proceeds from (payments on) Federal Home Loan Bank notes | ($700.0M) | $450.0M | $250.0M | $0 |
| Settlements related to deferred premium on derivatives | ($114.0M) | — | — | — |
| Payments on debt | ($5.0M) | ($5.0M) | ($603.0M) | — |
| Issuance of debt of consolidated investment entities | $736.0M | $948.0M | $297.0M | — |
| Repayments of debt of consolidated investment entities | ($527.0M) | ($526.0M) | ($351.0M) | — |
| Contributions from partners of consolidated investments | $126.0M | $29.0M | $111.0M | — |
| Distributions from partners of consolidated investments | $0 | $0 | ($92.0M) | — |
| Dividends on common stock | ($223.0M) | ($211.0M) | ($201.0M) | ($186.0M) |
| Dividends on preferred stock | ($44.0M) | ($44.0M) | ($35.0M) | — |
| Purchase of treasury stock | ($669.0M) | ($442.0M) | ($306.0M) | ($321.0M) |
| Issuance of preferred stock | $0 | $0 | $533.0M | — |
| Net cash provided by (used in) financing activities | $3.9B | $2.4B | ($6.3B) | ($2.2B) |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | $1.9B | $1.1B | ($1.6B) | $1.7B |
| Cash, cash equivalents, and restricted cash at beginning of period | $3.8B | $2.7B | $4.3B | $2.6B |
| Total cash, cash equivalents, and restricted cash at end of period | $5.7B | $3.8B | $2.7B | $4.3B |
| Line item | Jun 30, 2026 · YTD | Mar 31, 2026 · Q1 | Sep 30, 2025 · YTD | Jun 30, 2025 · YTD |
|---|---|---|---|---|
| Debt securities | $4.9B | $2.4B | $6.3B | $4.1B |
| Equity securities | $53.0M | $16.0M | $46.0M | $19.0M |
| Mortgage loans | $770.0M | $463.0M | $1.1B | $730.0M |
| Debt securities | ($9.8B) | ($4.0B) | ($11.0B) | ($6.8B) |
| Equity securities | ($51.0M) | $0 | ($21.0M) | $0 |
| Mortgage loans | ($1.6B) | ($724.0M) | ($1.2B) | ($751.0M) |
| Settlements related to derivatives and collateral on investments | $483.0M | ($471.0M) | ($977.0M) | ($928.0M) |
| Other investing activities | ($166.0M) | ($58.0M) | ($152.0M) | ($121.0M) |
| Net cash provided by (used in) investing activities | ($5.4B) | ($2.4B) | ($5.8B) | ($3.7B) |
| Net income (loss) | $240.0M | ($420.0M) | $258.0M | $167.0M |
| Net realized losses (gains) on investments | $68.0M | $47.0M | $111.0M | $175.0M |
| Net losses (gains) on derivatives | $2.1B | ($330.0M) | $2.5B | $1.3B |
| Net losses (gains) on funds withheld reinsurance treaties | $456.0M | $159.0M | $1.1B | $715.0M |
| Net (gain) loss on market risk benefits | ($383.0M) | $1.7B | ($183.0M) | $43.0M |
| (Gain) loss from updating future policy benefits cash flow assumptions, net | $38.0M | $18.0M | $37.0M | $24.0M |
| Interest credited on other contract holder funds, gross | $635.0M | $315.0M | $896.0M | $583.0M |
| Mortality, expense and surrender charges | ($253.0M) | ($127.0M) | ($393.0M) | ($263.0M) |
| Amortization of discount and premium on investments | ($30.0M) | ($14.0M) | ($32.0M) | ($18.0M) |
| Deferred income tax expense (benefit) | $19.0M | $19.0M | ($4.0M) | ($7.0M) |
| Share-based compensation | $74.0M | $60.0M | $106.0M | $72.0M |
| Accrued investment income | ($80.0M) | ($2.0M) | ($56.0M) | ($32.0M) |
| Deferred acquisition costs | $5.0M | $26.0M | $233.0M | $206.0M |
| Funds withheld, net of reinsurance | $224.0M | $120.0M | $108.0M | $168.0M |
| Future policy benefits | ($212.0M) | ($129.0M) | ($396.0M) | ($277.0M) |
| Other assets and liabilities, net | ($43.0M) | ($367.0M) | ($180.0M) | ($131.0M) |
| Net cash provided by (used in) operating activities | $2.9B | $1.0B | $4.1B | $2.8B |
| Deposits | $15.8B | $7.3B | $19.8B | $12.1B |
| Withdrawals | ($23.4B) | ($11.2B) | ($30.4B) | ($19.4B) |
| Net transfers from (to) separate accounts | $10.8B | $5.4B | $14.7B | $9.5B |
| Proceeds from (payments on) repurchase agreements and securities lending | ($558.0M) | ($531.0M) | ($520.0M) | ($383.0M) |
| Net proceeds from (payments on) Federal Home Loan Bank notes | $0 | $0 | ($700.0M) | ($700.0M) |
| Settlements related to deferred premium on derivatives | ($335.0M) | ($154.0M) | ($7.0M) | — |
| Proceeds from debt | $750.0M | — | — | — |
| Payments on debt | ($4.0M) | ($4.0M) | ($5.0M) | ($4.0M) |
| Pre-capitalized trust securities and debt issuance costs | ($17.0M) | — | — | — |
| Issuance of debt of consolidated investment entities | $31.0M | $96.0M | $494.0M | $395.0M |
| Repayments of debt of consolidated investment entities | ($236.0M) | ($35.0M) | ($152.0M) | ($98.0M) |
| Contributions from partners of consolidated investments | $96.0M | $108.0M | $27.0M | $17.0M |
| Dividends on common stock | ($126.0M) | ($64.0M) | ($169.0M) | ($115.0M) |
| Dividends on preferred stock | ($22.0M) | ($11.0M) | ($33.0M) | ($22.0M) |
| Purchase of treasury stock | ($454.0M) | ($227.0M) | ($517.0M) | ($360.0M) |
| Issuance of treasury stock | $500.0M | $500.0M | — | — |
| Net cash provided by (used in) financing activities | $2.8B | $1.2B | $2.5B | $968.0M |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | $282.0M | ($165.0M) | $795.0M | $17.0M |
| Cash, cash equivalents, and restricted cash at beginning of period | $5.7B | $5.7B | $3.8B | $3.8B |
Jackson Financial Inc. score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.